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Treatment outcomeObsessive–compulsive disorder (OCD) is a disabling mental health condition. Despite effective psychological
treatments for OCD, a signiﬁcant percentage of patients fail to experience lasting beneﬁt. Factors underlying var-
iable treatment response are poorly understood. Moderators of outcome can help understand “for whom” and
“under what circumstances” an intervention works best and thus improve service effectiveness.
This paper synthesizes the evidence on predictors and moderators and assesses the quality of reporting of
related analyses in psychological therapies for adults with OCD. Trials were identiﬁed through electronic searches
(CENTRAL, MEDLINE, PsycINFO, EMBASE), key author, and reference list searches of relevant systematic reviews.
Fifty ﬁve percent (38/69) of relevant trials reported baseline factors associated with outcome; these
encompassed clinical, demographic, interpersonal, OCD symptom-speciﬁc, psychological/psychosocial, and
treatment-speciﬁc variables. Predictors were commonly assessed via a validated pre-randomization measure,
though few trials adopted best practice by stating a priori hypotheses or conducting a test of interaction. Potential
associations emerged betweenworse OCD treatment outcome and the following factors: hoarding pathology, in-
creased anxiety and OCD symptom severity, certain OCD symptom subtypes, unemployment, and being single/
not married. However, the applied utility of these analyses is currently limited by methodological weaknesses.
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OCD is a disabling disorder, characterized by a pattern of repetitive
obsessive thoughts, images, or impulses and a ritualized pattern of
covert mental acts or overt behaviors, aimed at reducing the associated
anxiety and fear (APA, 2000). Data from the National Comorbidity
Survey Replication suggests a lifetime prevalence of OCD of 1.6%
(Kessler, Berglund, Demler, Jin, & Walters, 2005). OCD commonly
takes a chronic course (Ayuso-Mateos, 2002) and has been found to af-
fect multiple areas of functioning (Koran, Thienemann, & Davenport,
1996; Schneier, 1997). Although historically conceptualized as a signif-
icant treatment challenge (Foa, Franklin, & Kozak, 1998), research
efforts during the 1960s and 70s have led to substantial advances in
OCD treatments.
Psychological interventions have become an increasingly impor-
tant part of the management of this condition. On strength of evi-
dence, cognitive behavioral therapy (CBT) has been recommended
by the APA (2007) and the National Institute for Health and
Care Excellence (NICE, 2006) as the treatment of choice for OCD.
The core treatment component consists of exposure and response
prevention (ERP—aimed at the gradual habituation to anxiety-
provoking stimuli) and additional cognitive strategies, targeting irra-
tional and dysfunctional beliefs about the meaning and signiﬁcance
of obsessive thoughts (NICE, 2006). Systematic reviews have shown
such interventions to be highly effective in reducing symptoms
(e.g. Eddy, Dutra, Bradley, & Westen, 2004; Rosa-Alcázar, Sánchez-
Meca, Gómez-Conesa, & Marín-Matínez, 2008). However, average
effects from systematic reviews do not necessarily translate to the
individual patient. Despite moderate to large average treatment
effects, outcomes vary signiﬁcantly between trials and participants.
In a review by Abramowitz (2006), the author highlights that
despite signiﬁcant progress in the efﬁcacy and effectiveness of
psychological interventions in OCD, early drop-out and limited
response to the recommended psychological treatment for OCD
leavearound 50% of patients clinically unwell. Similarly, Eddy etal.
(2004) found that while around two thirds of treatment completers
improved, only half of those who failed to complete treatment
showed improvements on the Yale–Brown Obsessive-Compulsive
Scale (Y–BOCS).
The ability to prospectively distinguish treatment responders from
non-responders has interested researchers for many years (e.g.Fritzler, Hecker, & Losee, 1997; Barrett, Farrell, Dadds, & Boulter, 2005;
De Araujo, Ito, & Marks, 1996; Marks etal., 1988; McLean etal., 2001).
The potential utility of identifying factors which can reliably predict
treatment response is substantial. In research, moderators can inform
the selection of inclusion and exclusion criteria for stratiﬁcation in
future randomized trials (RCTs) to maximize statistical power, while
in clinical practice they can help to identify those atrisk of a poor prog-
nosis and may inform the matching of individual patients with suitable
treatments (Kraemer,Wilson, Fairburn, & Agras, 2002). Although awide
range of potential predictors have been identiﬁed, there remains limited
consensus about what factors are associated with response to psycho-
logical treatments in OCD, limiting their applied impact on routine
treatment decision-making.
Through a narrative synthesis of 49 open and controlled trials,
Keeley and colleagues summarized predictors of response to CBT in
OCD (Keeley, Storch, Merlo, & Geffken, 2008). The authors reported a
number of variables to be consistently associated with outcome. These
comprised: the strength of the therapeutic relationship, the nature of
patients' family environment, and several different clinical factors—
OCD severity, symptom subtype, severe depression, and concurrent
personality disorder (Keeley et al., 2008). However, Keeley et al.
(2008) acknowledge the largely conﬂicting nature of the evidence and
limitations in the interpretability of ﬁndings due to differences in the
measurement of respective predictors. Moreover, these ﬁndings ought
to be considered in light of a number of limitations of this review. This
synthesis included both open and controlled trials, and adult and pedi-
atric samples (Keeley et al., 2008). Importantly, the analyses of predictor
effects failed to consider the quality of either the included studies or the
predictor analyses conducted. Considering these limitations and the
substantial research activity since Keeley et al.'s (2008) reviewwas pub-
lished, the present systematic review serves to update and strengthen
existing evidence on predictors and moderators of response to psycho-
logical therapies in OCD. In this synthesis, the following three questions
have been addressed:
• What predictors/moderators of outcome have been measured in
psychological therapies for OCD?
• What proportion of OCD trials adopts methodological best practice in
the assessment of predictors/moderators?
• What is the existing evidence base concerning these predictors/
moderators and their relationship with OCD treatment outcome?
Table 1
Characteristics of moderators of outcome.
Criterion Moderator characteristic
Type of question When/for whom a cause–effect relationship occurs
Stability of predictor
variable
Trait, i.e. a relatively stable characteristic, innate
attribute, enduring process, or disposition of an
individual/context/environment/situation
Sequence of operation Precedes IV and DV
Relationship with IV Uncorrelated with IV
Function in the causal
relationship
3rd variable modifying the causal relationship
Applied function Clinical practice:
–Inform personalized
treatment decisions
Research practice:
–Inform stratiﬁcation in RCTs
for greater statistical power
–Inform inclusion criteria for
greater sample homogeneity
Note. DV = dependent variable; IV = independent variable; RCT = randomized
controlled trial. Information adapted from MacKinnon and Luecken (2008); Wu and
Zumbo (2008).
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2.1. Identiﬁcation of studies
The PRISMA guidelines for reporting of systematic reviews and meta-
analyses were followed (The PRISMA Group, 2009).1 Articles were pri-
marily identiﬁed through an electronic literature search on the Cochrane
Collaboration's Clinical Trials Register (CENTRAL), completed in January
2012, using the MESH-, and text term “obsessive–compulsive disorder”
and the text terms “OCD OR obsessive–compulsive neurosis”. Previous
authors have demonstrated 94% sensitivity for a search for randomized
controlled trials using only CENTRAL (Royle & Waugh, 2005). In view of
the potential delays in uploading trials onto CENTRAL, this primary search
was supplemented by additional searches using the MEDLINE, PsycINFO,
and EMBASE databases for relevant articles published between 2009 and
January 2012, using the text, and MESH terms “obsessive–compulsive
disorder” OR “OCD” in combination with “psychological intervention”
and “randomized controlled trial”. Database searcheswere supplemented
by a key author search. We also identiﬁed 25 relevant published system-
atic reviews on the Cochrane database (Cochrane Database of Systematic
Reviews and DARE) and screened these for additional relevant articles.2
ZETOC automated literature alerts, targeting key journals in the domains
of medicine and psychology, were also employed to identify studies
published in the time period following themain searches. Study inclusion
was determined on the basis of the following criteria: (a) adultswith a di-
agnosis of OCD, consistent with DSM-, ICD-, or equivalent international
diagnostic criteria (e.g. CCMD in the Chinese literature), (b) at least one
treatment condition involved a psychological intervention, deﬁned as a
structured “process designed to bring about modiﬁcation of feelings,
cognitions, attitudes, and behaviour” (Strupp, 1978, p. 3), (c) studies
were published in full-text within the search-period and adopted a
randomized-controlled, quasi-random, or cross-over design, as deﬁned
in Cochrane criteria, (d) papers were not excluded on the basis of
language of publication (non-English papers included N = 3), and (e)
studies reported on the relationship between baseline variables and
treatment outcome.
2.2. Coding of study characteristics
All predictors reported in relevant studies were noted. This report
focuses on those predictive factors assessed pre-randomization, which
may be conceptualized as potential moderators of treatment response
(Baron & Kenny, 1986). Table 1 provides a summary of key characteris-
tics of moderators.
Predictor analyses were presented in a number of different ways.
Hence, we categorized analyses as follows:
1) Moderator effect—where the effect of the baseline variable on out-
come was assessed through a direct test of the interaction between
the baseline variable and the intervention(s).
2) Non-speciﬁc predictors of outcome, where the main effect of a
predictor on outcome was assessed for the sample as a whole.
3) Subgroup analyses involving splitting of trial dataset into different
groups:
(a) Non-speciﬁc predictors of outcome, where the main effect of a
predictor on outcome was assessed within the treatment or
control group only.
(b) Taking a subgroup of patients from the treatment and control
groups and comparing intervention with control patients with-
in that subgroup.
(c) Splitting the overall sample into two groups and analyzing sta-
tistical signiﬁcance in both groups separately (e.g. splitting the1 Review protocol available from corresponding author upon request.
2 List of systematic reviews is available in Appendix A.sample into those with and without baseline depression and
assessing outcome for both groups separately).
Initial study selection was conducted by the ﬁrst author, who
excluded studies which were not within the scope of this review.3 A
reliability check of this initial screen was conducted by an independent
researcher for a 10% random sample (kappa = 0.95). The remaining
studieswere assessed as full-texts. Additionally, a reliability check of ex-
clusion at the full-text stage was conducted for 25 studies by one of the
study authors (kappa = 1). Two of the review authors independently
extracted data on the study characteristics, main outcomes, and predic-
tor effects. Discrepancies were discussed between the two authors;
when agreement could not be reached, a third author was consulted.
Predictor variables were categorized post hoc into six groupings:
• Clinical − illness and treatment context characteristics, not part of/
linked to the OCD intervention treatment speciﬁcally; e.g. referral
source, comorbidities.
• Demographic − characteristics relating to the OCD study sample/
population; e.g. age, gender, educational status.
• Interpersonal − characteristics of the OCD sample's interpersonal
environment/situation; e.g. marital or relationship status; marital
satisfaction.
• OCD symptom-speciﬁc− variables relating speciﬁcally to OCD symp-
toms; e.g. OCD symptom severity, OCD illness duration, and age of
OCD onset.
• Psychological/psychosocial − variables relating to psychological and
psychosocial characteristics of the OCD sample or the individual
patient; e.g. treatment expectancy and motivation, IQ.
• OCD treatment-speciﬁc− treatment context variables, part of/specif-
ic to, the intervention treatment(s).
The criteria for the quality assessment of predictor and moderator
analyses were based on existing quality criteria outlined in two recent
publications by Pincus et al. (2011) and Sun et al. (2012):
• Predictors assessed through a validated assessment tool: The assess-
ment of predictor variables through non-validated tools may call
into question the reliability and validity of the constructs tested.
• Predictor measures taken pre-randomization: Predictors ought to
be measured pre-randomization as some may change following
group allocation. This criterion does not apply to procedural or un-
modiﬁable variables, e.g. age.
• b5 predictors tested: The precision of a predictor model decreases
with the number of factors in the model; measuring fewer variables
may increase the reliability/credibility of identiﬁed predictor effects.3 Table of excluded studies is available in Appendix B.
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predictors ought to be theory-, or evidence-driven with the view to
produce conﬁrmatory results. Hence, authors ought to state the
anticipated predictor effect. Post hoc testing of predictor effects can
at best offer exploratory ﬁndings.
• Analysis method-direct test of interaction between predictor and
treatment type: A moderator by deﬁnition interacts with the
independent variable X to predict the outcome variable Y (e.g. age
may interact with treatment condition to predict outcome). Thus, to
show that a moderation effect has occurred, a test of the interaction
between the moderator and X should be conducted.
The above list represents the key quality criteria agreed by the re-
viewauthors on the basis ofwhich each predictor variablewas assessed.
The selection of these speciﬁc criteria was based on their importance in
the relevant methodological publications (Pincus et al., 2011; Sun et al.,
2012) and their relevance in the context of the presented literature. For
each predictor (e.g. OCD symptom severity), a percentage score of the
number of analyses which met these criteria (where applicable) was
calculated. This score reﬂects the quality of the predictor/moderator
analyses, not the quality or risk of bias of included studies as a whole.
To determine the risk of bias of included trials we conducted a
quality assessment, based on criteria derived from the Cochrane
Collaboration's tool for the assessment of risk of bias (Higgins &
Altman, 2008). Intervention ﬁdelity, manualization of treatment, gener-
ation of random allocation sequence, allocation concealment, blinding
of outcome assessors, intention-to-treat analysis, and levels of study at-
trition at post-treatmentwere assessed. Rates of attrition were grouped
into categories of b5%, 5–20%, and N20%. Participant blinding was not
assessed, as this is generally not relevant in the context of psychological
interventions. For quantitative analyses of risk of bias, a dichotomised
score of allocation concealment (low versus uncertain/high risk of
bias) was used, as this is most reliably associated with outcome
(Pildal, Hróbjartsson, Jørgensen, Altman, & Gøtzsche, 2007; Schulz,
Chalmers, Hayes, & Altman, 1995) and may be of greater relevance in
the context of psychological therapies, where other key quality criteria
such as adequate blinding of participants and personnel are rarely pos-
sible (Bower et al., 2013). Quality scores were assessed independently
by two of the review authors. Discrepancies in quality ratings were
resolved through discussion amongst the research team.
2.3. Analysis
2.3.1. Publication bias
Assessing study characteristics associated with the reporting of
predictor/moderator analyses may aid interpretation and use of ﬁnd-
ings (Sun et al., 2011), as it may suggest bias in reporting of such analy-
ses. Hence, we identiﬁed all trials relating to psychological therapies in
OCD, and distinguished those which reported and did not report base-
line predictors/moderators of outcome. We assessed whether differ-
ences in risk of bias, sample size, year (divided arbitrarily into studies
published 2002 onwards and those published prior) and country of
publication (coded “USA/Canada” and “other”), and treatment effect
were associated with the reporting of predictor/moderator analyses.
The selection of these characteristics was determined post hoc. Treat-
ment effect sizes were compared through meta-analysis, using STATA
software version 11 (StataCorp., 2009). Only trials comparing active
with control conditions (waitlist; attention placebo), and those
assessing the independent effect of one ormore psychological interven-
tions (e.g. psychological intervention plus drug versus drug) were in-
cluded in the meta-analysis. Where authors failed to report means and
standard deviations (N = 2; Fals-Stewart, Marks, & Schafer, 1993;
Jones &Menzies, 1998), effect sizes were estimated usingmethods pre-
viously outlined by Lipsey and Wilson (2000). Missing standard devia-
tions were calculated by taking the median standard deviation from
other studies included in this review.2.3.2. Predictors and moderators of outcome
The optimal analysis would have involved assessment of the
relationship between predictors/moderators and treatment outcome
through meta-analysis of appropriate interaction statistics (Hunter &
Schmidt, 2004). However, many of the included studies failed to report
the necessary data from which to calculate an effect size of the interac-
tion. Without the option for meta-analysis, published analyses have
adopted a narrative synthesis approach (Keeley et al., 2008). Narrative
integrationsmay be deﬁned as a non-quantitative way “to portraymul-
tiple ﬁndings in a connected, verbal report” (Smith, Glass, & Miller,
1980, p.36). Here, we adopted a box-score approach. This involved
tabulating predictors and their reported relationship with outcome,
deﬁned in terms of signiﬁcance and direction (negative, positive, or no
relationship; e.g. Green & Hall, 1984); included studies falling into
each respective group were tallied and the majority of studies
falling into any speciﬁc category is considered to indicate the likely
relationship between the predictor and outcome (Light & Smith,
1971). The box-score approach enables basic quantiﬁcation of reported
predictor effects and the identiﬁcation of patterns across the literature.
It also facilitates some assessment of the relationship between
quality of analyses and reported effects. We consider the advantages
and disadvantages of this approach in more detail in the Discussion
section.
A small number of included papers reported overlapping samples.
Where this was the case, predictor effects tested for the whole sample
were reported while effects tested for patient subgroups were excluded
from the analyses to avoid the double-reporting of data relating to the
same sample.When study authors assessed the impact of the same pre-
dictor via multiple statistical tests, these were ordered by rigor and re-
sults of the most adequate form of analysis (ordered as: test of the
interaction between the predictor and treatment type(s), multivariate
analyses of main predictor effects, univariate analyses of predictor ef-
fects, and correlation analyses). This grading of analysis quality was
based on relevant methodological publications, highlighting the superi-
ority of interaction tests in producing reliable results in the assessment
of baseline predictors of outcome (Brookes et al., 2004; Schulz &Grimes,
2005). Where the impact of the same predictor was assessed for multi-
ple time-points and outcome measures within studies, the results clos-
est to post-treatment for a measure of overall OCD symptom severity
were reported. Where there was a conﬂict between the quality of the
statistical analysis and the dependent variable of interest, the appropri-
ate outcome measure was prioritized.
In light of the substantial number of predictors reported, the box-
score assessment of the predictor/moderator-outcome relationship
was limited to those predictors reported in ≥5 studies (see Fig. 2).
3. Results
In the subsequent paragraphs we present the following data:
1) Description of trial characteristics.
2) Description of the predictors/moderators measured and outcomes
for which predictor effects were assessed.
3) Analyses of publication bias.
4) Box-score analysis of predictors/moderators of outcome.
5) Risk of bias of included studies.3.1. Characteristics of included studies
A PRISMAdiagramdetails the study identiﬁcation and selection pro-
cess (Fig. 1). Thirty eight trialsmet the study inclusion criteria. A further
31 trials of psychotherapy for OCD, which did not attempt the analysis
of predictors of outcome, were used solely in the assessment of publica-
tion bias. The following study characteristics relate to the 38 studies
included in this review of predictor effects.
Studies excluded from analysis of predictors
with reasons:
1) No predictors assessed N=26
2) Only non-baseline factors assessed N=5
Full-text articles excluded with reasons: 
1) Irrelevant study design N=62
2) Irrelevant intervention/intervention design 
N=33
3) Irrelevant sample N=30
4) No separate data for OCD patients N=6
5) No diagnostic tool stated N=24
6) Duplicate articles N=7
Studies included in analysis of 
predictors N=387
Eligible papers N=116
Eligible studies N=69
Studies included in meta-analysis 
N=28/Comparisons N=34
Combined unique records N=2624 
Full-text articles assessed for 
eligibility N=278
Records identified through 
other sources N=39
Records excluded for not meeting 
inclusion criteria N=2328
Unobtainable N=18
Records identified through 
electronic sources N=3019
Fig. 1. PRISMA diagram of study identiﬁcation and selection.
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size = 65, SD = 42.7). Participants had a mean age of 35.3 years and
on average study samples consisted of a slightly greater number of
women than men. All studies included OCD patients only. Two
studies recruited patients on the basis of primary obsessions with no
apparent compulsive symptoms, or compulsions unrelated to-, or less
severe than obsessive symptoms (Freeston et al., 1997; Whittal,
Woody, McLean, Rachman, & Robichaud, 2010). Fifty percent of
included trials offered information on the symptom breakdown of the
OCD sample.
Study interventions varied signiﬁcantly in terms of content, dura-
tion, intensity, and delivery. Eight trials includedminimal-contact treat-
ments, involving less than 10 h of patient–therapist contact (NICE,
2006); in four of these, treatment was delivered remotely, substituting
patient–therapist interactionwith computerized ormanualized therapy
tools. Intervention content was largely based on CBT principles. Ninety
three percent of psychological interventions were categorized as CBT,
comprised of ERP and cognitive techniques. The remaining interven-
tions consisted primarily of (a) cognitive therapy without ERP and (b)
other treatment approaches (Stress Management Training). On average
participants received 17.9 treatment sessions (SD = 13.3). In those
studies offering face-to-face treatment, session duration ranged be-
tween 30 and 150 min and the average intervention intensity was
22.7 h (SD = 12.2). Study interventions were delivered by a wide
range of professionalswith varying levels of experience and training, in-
cluding clinical psychologists, psychiatrists, counselors, social workers,
and students in related ﬁelds.3.2. Predictors/moderators and outcomes
Characteristics of the 38 included studies, baseline predictors/moder-
ators, and the outcomes for which they were assessed are speciﬁed in
Table 2. Three studies speciﬁcally assessed mediation effects (Simpson
et al., 2010; Van Balkom et al., 1998; Van Oppen et al., 1995) and one
study assessed a moderated mediation model (Whittal et al., 2010).
These meditational analyses are not reported further here.
While study authors reported a wide range of different predictors
(Fig. 2), certain variables and categories of predictors were farmore com-
monly assessed. Most frequently, OCD symptom-speciﬁc variables were
reported, including OCD symptom severity, illness duration, symptom
subtypes, obsessive–compulsive beliefs, and age of illness onset. Similarly,
clinical variables, not directly associated with OCD were commonly
reported; within this category, depression severity, medication use, past
treatment, and anxiety severity were assessed. These were followed
by demographic variables (age, gender, employment, and educational
status), the interpersonal factor (marital/relationship status) and a
psychological predictor (treatment expectancy).
3.3. Comparison of trials with and without predictor analyses
Comparative analyses indicated that two study characteristics
were signiﬁcantly associated with the reporting of predictor or
moderator analyses. Trials reporting predictor analyses were larger
(respective mean sample sizes: 65 versus 42.7) and at lower risk of
bias [χ2 (1, 69) = 4.3, p = .039; Table 3] than those which did not.
Table 2
Characteristics of included studies.
Author/year Country Study design Sample
size
Intervention(s) Psychological
intervention
intensity
Control group(s) Predictor/moderator variables Outcome variables
Althaus et al. (2000) Germany RCT 30 OCD-speciﬁc group CBT;
generic group CBT
U/C Na Age; OCD symptom duration OCD symptom reduction; depressive symptom
reduction; therapist-rated overall state/
symptoms; subjective improvement
Belotto-Silva et al.
(2012)
Brazil RCT 158 Group CBT; ﬂuoxetine 30 h Na Age; gender; MDD; comorbidity (social
phobia; dysthymia; PTSD; BD;
compulsive buying)
OCD symptom reduction
Valpato Cordioli
et al. (2003)
Brazil RCT 47 Group CBT 24 h WL OCD severity; intensity of overvalued ideas;
age at illness onset; comorbid anxiety/
depression; anti-obsessional medication use
Relapse; OCD severity
Cottraux et al.
(1990)
France RCT 60 BT + ﬂuvoxamine U/C Anti-
exposure + ﬂuvoxamine/
BT + placebo
Pre-tx depression severity; OCD symptom
duration; tx expectancy; behavioral
avoidance; target compulsions;
compulsive activity checklist
Compulsive symptoms (duration/day);
tx success
Cottraux et al.
(2001)
France RCT 65 CT; BT 20 h Na Tx expectancy; pre-tx severity of OCD/
depression/responsibility/interpretations of
intrusive thoughts/obsessive thoughts
OCD symptom reduction
De Araujo et al.
(1995)
UK RCT 56 BT (in vivo & imaginal
exposure); BT (in vivo
exposure only)
13.5 h Na OCD symptom subtype (primary washing/
cleaning compulsions); age; gender; OCD
symptom duration; age at illness onset;
referral source; non-OCD psychiatric
symptoms; pre-tx severity of OCD/target
obsessions/compulsions/depression/
avoidance/free-ﬂoating anxiety/overall
well-being/work & social adjustment/beliefs;
medication use
Change in target compulsions/obsessions/
overall well-being (CGI); compliance
at week 1
Dreessen et al.
(1997)
Netherlands RCT 52 CT; BT; CBT 12 h Na PD trait/sub-threshold (avoidant; dependent;
OC; paranoid; schizotypal; self-defeating;
passive-aggressive); N of PDs; N of PD traits/
sub-clinical PDs; ≥1 PD/sub-threshold PD
OCD symptom reduction/change/recovery;
composite score (MOCI/BAT); composite
score (MOCI/BAT/LOI/Rational Belief
Inventory/Depressive Symptoms Inventory);
OCD recovery; behavioral avoidance
reduction/change
Emmelkamp et al.
(1990)
Netherlands RCT 54 Partner-assisted BT;
patient-based BT
Min. 6.75 h Na Marital distress OCD severity; anxiety-related discomfort;
marital adjustment; problem-solving
capacity; depression; state/trait anxiety;
anger; curiosity
Fineberg et al.
(2005)
UK Quasi-random
study
48 Group CBT 24 h Group relaxation OCD symptom duration; anti-obsessional
medication use
OCD symptom change/reduction
Foa et al. (1984) USA Quasi-random
study
32 Exposure/response prevention/
combined ERP
38 h Na Hospitalization Compulsion checklist; urge to ritualize; main
fear; anxiety during exposure; avoidance of
daily activities; severity of obsessions/
compulsions; anxiety/depression; general
functioning; time spent on compulsions
Foa et al. (2005) USA RCT 122 BT; BT + clomipramine 40/46 h Clomipramine; placebo Tx site; OCD severity OCD severity; time to relapse; drop-out status
Freeston et al.
(1997)
Canada RCT 38 CBT 60 h WL Pre-tx credibility; pre-tx expectancy Tx outcome (U/C)
Greist et al. (2002) USA/
Canada
RCT 218 Computerized CBT;
therapist-led CBT
HW only/10 h Progressive muscle
relaxation
OCD symptom subtype (ritual type; hoarding
symptoms; sexual & religious obsessions);
prior SSRI tx; tx site; tx expectations; pre-tx
severity of OCD/depression
% tx goals considered completed; OCD
symptom reduction; early tx
discontinuation
Jaurietta et al.
(2008)
Spain RCT 57 Individual/group CBT 15/30 h WL OCD symptom subtype (contamination/
cleaning obsessions; ordering/symmetry
obsessions; hoarding obsessions/
compulsions; checking obsessions/
compulsions; slowness); employment status
Depression-, anxiety-, OCD symptom
reduction
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Author/year
Country Study
design
Sample size Intervention(s) Psychological
intervention
intensity
Control group(s) Predictor/moderator variables Outcome variables
Jónsson et al.
(2011)
Denmark RCT 110 Individual/group CBT 19/37 h Na Responsibility; thought-action fusion; pre-tx
severity of OCD/depression; age; gender; age
at illness onset; OCD symptom duration; OCD
symptom subtype; educational level;
employment status; relationship status;
comorbid Axis I/II comorbidities;
medication use
OCD symptom reduction/change
Keijsers et al.
(1995)
Netherlands Cross-over
study
U/C Phase 1: Exposure; Phase2:
Response prevention
(vice versa)
8 h (per
treatment
phase)
Na AD medication use; pre-tx compulsive
behavior/obsessive fear; depression; OCD
symptom duration; tx motivation; marital
satisfaction
Compulsive behavior; obsessive fear;
tx success
Kenwright et al.
(2005)
UK RCT 44 Computerized
CBT + scheduled/requested
help-line support
U/C Na Tx preference; age; gender; OCD symptom
duration; past BT; SRI medication use
OCD severity
Lakatos (1997) Germany RCT 28 CBT; BT U/C Na Pre-tx depression severity OCD severity; drop-out status
Marks et al. (1988) UK RCT 49 Self-controlled
BT + clomipramine; self- &
therapist-controlled
BT + clomipramine
U/C Anti-
exposure + clomipramine
Age; gender; marital status; OCD symptom
duration; age at illness onset; OCD severity; tx
expectancy; factor analyzed OCD symptom
clusters
Drop-out status; target compulsions;
time spent on compulsions; severity of
obsessions/compulsions; social disability/
adjustment; free-ﬂoating anxiety;
depression; habituation to brief neutral/
aversive stimuli
Marks et al. (2000) UK RCT 15 Computerized CBT;
therapist-led CBT
HW only/10 h Progressive muscle
relaxation
Pre-tx discomfort during/after OCD imagery Work-social adjustment; severity of OCD/de-
pression
McLean et al.
(2001)
Canada RCT 93 Group BT/; group CBT 30 h WL OCD symptom subtype; age; pre-tx OCD
severity; medication use; gender; belief
measures (U/C); depression; disability status;
educational level; age at illness onset; OCD
symptom duration; pre-tx thought-action
fusion/responsibility/obsessive beliefs/
thematic similarity (of OCD symptom
content across tx group members)
Drop-out status; OCD severity/improvement;
recovery status; tx refusal
Meyer et al. (2010) Brazil RCT 93 MI + thought
mapping + group CBT;
Information + group CBT
26 h Na Age; gender; age at illness onset; OCD
symptom duration; age at symptom
interference; depression; pre-tx overall
well-being (CGI); OCD severity
Drop-out status
Nakao et al. (2005) Japan RCT 32 BT + placebo 9 h Autogenic
training + placebo;
autogenic
training + ﬂuvoxamine
OCD symptom duration OCD symptom reduction
Nakatani et al.
(2005)
Japan RCT 28 BT + placebo 9 h Autogenic training Age at illness onset; OCD symptom duration;
IQ; history of MDD; pre-tx severity of obses-
sive/
compulsive symptoms; OCD symptom
subtype; pre-tx OCD severity; pre-tx overall
well-being (CGI)
OCD symptom reduction
Rector et al. (2009) Canada RCT 29 CBT for OCD & MDD; CBT
for OCD
20 h Na Age Drop-out status
Rowa et al. (2007) Canada RCT 37 Home-/ofﬁce-based BT 21 h Na OCD related impairment U/C
Simpson et al.
(2008)
USA RCT 111 BT (authors class as
CBT) + SSRI
41 h CBT (SMT) + SSRI Tx site; OCPD diagnosis/severity; pre-tx OCD
severity, QoL; N of comorbid Axis I/II
disorders; N of past SRI trials; depression;
anxiety; satisfaction with social situation;
gender; OCPD symptoms (preoccupationwith
details; perfectionism; excessive devotion to
work; hyper-morality; inability to discard;
reluctance to delegate tasks; miserliness;
rigidity/stubbornness); age; marital status;
employment status; OCD symptom insight;
OCD symptom subtype (hoarding); OCD
symptom duration
OCD severity; satisfaction with social
situation; depression; anxiety; QoL
(continued on next page)
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Table 2 (continued)
Author/year Country Study design Sample
size
Intervention(s) Psychological
intervention
intensity
Control group(s) Predictor/moderator variables Outcome variables
Simpson et al.
(2010)
USA RCT 30 MI + BT; BT Min. 27 h Na Pre-tx OCD severity; depression severity; OCD
symptom insight; QoL; Axis I comorbidity; N
of past SRI trials; gender; employment status;
OCD symptom subtype (hoarding); readiness
to change; work impairment
OCD severity
Sousa et al. (2006) Brazil RCT 56 Group CBT; Sertraline 24 h Na Pre-tx AD medication use OCD severity
Tenneij et al.
(2005)
Netherlands RCT 96 BT + medication 17.5 h Medication OCD severity; depression/anxiety symptoms;
OCD symptom duration; age
Drop-out status
Tolin, Frost, and
Steketee (2007)
USA RCT 41 Patient-/therapist-led BT U/C Na Pre-tx expectancy OCD symptom change (post-tx; 1, 3,
6 months follow-up)
Tolin, Diefenbach,
and Gilliam
(2011)
USA RCT 34 Stepped-care BT; BT 36 h Na Depression OCD symptom change; treatment cost
1) Van Oppen et al.
(1995)/2) Van
Balkom et al.
(1998)a
Netherlands RCT(s) 1) 71
2) 117b
CT; BT; CT + ﬂuvoxamine;
BT + ﬂuvoxamine
12 /11 h WL Pre-tx OCD severity; tx motivation; comorbid
PD; age at illness onset; marital/relationship
status; prior tx; employment status; OCD
symptom duration; depression; psychiatric
symptoms (SCL-90); referral source; gender;
age; anxiety symptoms; OCD symptom
subtype; N of Axis I comorbidities;
rumination; impulses; precision; irrational
beliefs; tx site; MDD
OCD severity/remission; response status;
drop-out status; outcome (U/C)
Van Oppen et al.
(2010)
Netherlands RCT 118 Self-/therapist-led BT
(experienced vs.
inexperienced therapist)
6.5/16.5 h Na Gender; education level; OCD symptom
duration; comorbid Axis I disorders; prior tx;
employment status; marital status; severity of
OCD/
depression; anxiety-related
discomfort
Drop-out status
Vogel, Stiles, and
Götestam (2004)
Norway RCT 37 ERP + CT; ERP + relaxation 24 h WL Age; gender; marital status; pre-tx OCD
severity; tx motivation; tx expectancy;
comorbid GAD/panic disorder; Cluster
A/B/C PD
OCD severity; drop-out status
Whittal et al.
(2005)
Canada RCT 83 BT; CBT 12 h Na Pre-tx severity of OCD/depression; tx
credibility; education level; employment
status; disability status; marital status; age;
ethnicity; medication use; comorbid Axis I
disorders; age at illness onset; referral source;
gender; OCD symptom duration
Drop-out status; tx refusal; OCD severity
Whittal et al.
(2010)
Canada RCT 73 CBT; stress management
training
13 h WL Medication use; depression; referral source;
psychosocial stressors (U/C); educational level
Tx effect (U/C); drop-out status
Note. AD = antidepressant; BD = Bipolar Disorder; BAT = Behavioral Avoidance Test; BT = behavior therapy; CGI = Clinical Global Impression; CT = cognitive therapy; CBT = cognitive behavior therapy; ERP = exposure and response
prevention; GAD = Generalized Anxiety Disorder; h = hours; HW = homework; IQ = intelligence quotient; LOI = Leyton Obsessional Inventory; MI = motivational interviewing; MDD = Major Depressive Disorder; Min. = minimum;
MOCI = Maudsley Obsessional Compulsive Inventory; N = number; Na = not applicable; OC = obsessive compulsive; OCD = Obsessive–Compulsive Disorder; OCPD = Obsessive Compulsive Personality Disorder; PD = Personality Disorder;
pre-tx = pre-treatment; PTSD = Post-Traumatic Stress Disorder; QoL = quality of life; RCT = randomized controlled trial; relax. = relaxation; SCL-90 = Symptom Checklist-90; (S)SRI = (selective) serotonin reuptake inhibitor; tx = treat-
ment; U/C = unclear; WL = waitlist.
a Predictors assessed for combined dataset from both trials.
b Approximately 50% of participants took part in both trials.
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Table 3
Comparisons of study characteristics in trials with and without predictors of outcome.
Study
characteristic
All trials
N/Mean
(SD)
Trials with
predictor
analyses
N/Mean (SD)
Trials without
predictor
analyses
N/Mean (SD)
Comparison
Year of publication
1984–2001
2002–2012
31
38
14
24
16
15
χ2 (1,69) = .974,
p = .324
Country
USA/Canada
Other
21
48
13
25
8
23
χ2 (1,69) = .111,
p = .739
Risk of bias
Low
Uncertain/high
13
56
11
27
2
29
χ2 (1,69) = 4.275,
p = .039
Sample size 54.5 (36.7) 65 (42.7) 42.7 (24.1) U = 372.0,
p = .028
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The following paragraphs synthesize the existing evidence of predic-
tor effects, the quality of predictor analyses, and overall risk of bias.
3.4.1. Predictors/moderators included in the box-score analysis
Seventeen trials reported the effect of overall baseline OCD symp-
tom severity on outcome. Two studies assessed the effect of obsessive
or compulsive symptoms only (Cottraux et al., 1990; Keijsers et al.,
1995) and one study assessed the effect of a measure of general illness
severity, derived through a factor analysis (Marks et al., 1988). A further
study reported conﬂicting data within respective trial reports (Simpson
et al., 2008); these studies were excluded from the box-score analysis.
Nineteen trials reported the effect of baseline depression on treatment
outcome; of these, one study failed to report data to judge the direction
of the relationship and was therefore omitted from the box-score anal-
ysis (Greist et al., 2002). The relationship between age and treatment
outcome was assessed in 14 of the included trials; one study reported
conﬂicting ﬁndings in respective trial reports andwas therefore exclud-
ed (Vogel et al., 2004). Genderwas assessed in 13 studies; one trialwith
conﬂicting reports of predictor effects was excluded (Vogel et al., 2004).
The effect of OCD symptom content was assessed in ten trials; one of
these was excluded from the box-score analysis as the symptomTx-specific
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Fig. 2. Horizontal bar graph of predictors assessed across trials by predictor category. Note. BAT
GAD = Generalized Anxiety Disorder; IQ = intelligence quotient; OC = obsessive compulsi
Disorder; PD = Personality Disorder; PTSD = Post-Traumatic Stress Disorder; QoL = qualityclusters assessed were derived from a factor analysis and did not corre-
spond with validated OCD symptom subtypes (Marks et al., 1988).
Consistent signiﬁcant associations between predictors and treatment
outcome were rare among the commonly assessed variables (Table 4).
For many predictors, including OCD symptom severity, OCD symptom
subtype, OCD illness duration, age, gender, marital/relationship status,0 2 4 6 8 10 12 14 16 18 20
Number of studies reporting predictors
/group therapy
Tx site
IQ
iness to change
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Tx credibility
Tx motivation
Tx expectancy
ronicity factor
sessions factor
 OCD imagery
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= behavioral avoidance test; BD = Bipolar Disorder; CGI = Clinical Global Impression;
ve; OCD = Obsessive–Compulsive Disorder; OCPD = Obsessive Compulsive Personality
of life; SES = socio-economic status; Tx = treatment.
Table 4
Box-score review of predictor effects on OCD treatment outcome and quality assessment.
Predictor effects on outcome Quality assessment for combined analyses of speciﬁc predictors
Predictor/moderator Test of
interaction
Predictor: All Predictor:
Subgroup
Valid measure
of predictor
Predictor tested
prerandomization
b5 predictors
assessed
A priori
hypothesis
Direct test of
interaction
Y Y Y Y Y
OCD symptom severity +(SMT) 0(ERP) + +++ 0 0 0 0 0 0 0 0 0 0 100% 87% 7% 7% 7%
Comorbid depression severity 0 0 0 + 0 0 0 0 0 0 0 0 0 0 ?a + 0 0 100% 84% 11% 0% 16%
OCD illness duration + 0 0 0 0 0 0 0 0 0 0 0 0 ?a + +(IG)
0(CG) 0
Na Na 18% 0% 6%
Patient age 0 0 +++ 0 0 0 0 0 0 0 0 Na Na 14% 0% 14%
Patient gender 0 0 0 0 0 0 0 0 Na Na 0% 0% 15%
Male 0 +
Female + 0
Patient medication use 0 0 − 0 0 0 0 0 0 0 Na Na 20% 0% 20%
OCD symptom subtypes + 0 0 +(cCBT) 100% 93% 0% 27% 13%
Washing vs. checking 0
Aggressive/contamination
obsessions
0
Cleaning/contamination + 0 +(FLV)
0(ERP)
Checking + 0
Hoardingc 0 +++
Sexual/religious +
Ordering/symmetry +
Slowness +
Age at OCD onset 0 0 0 0 0 0 0 0 0 Na Na 0% 0% 0%
Patient employment status 0 −− 0 0 0 0 Na Na 0% 0% 14%
Patient marital/relationship
status
0 −− 0 0 0 0 Na Na 0% 0% 14%
OCD tx expectancy − 0 0 0 0 ?b 0 0% 29% 29% 0% 0%
Past OCD tx + 0 0 0 0 0 Na Na 0% 17% 17%
OC beliefs 0 0 94% 100% 0% 25% 6%
Thought–Action Fusion +(Moral subscale
only) 0
Obsession-related beliefs/
thoughts (IBRO/OTC)
0 +(CT)
0(ERP)
Responsibility 0 0 0
Intrusive thought
interpretation (ITIQ)
0
Intensity, rigidity, insight (OVIS) 0
Insight 0 0
Irrational beliefs (IBI) 0
Patient educational level 0 0 0 0 0 Na Na 0% 0% 20%
Comorbid anxiety severity + 0 0 0 0 + 100% 83% 0% 0% 17%
Total quality score 82.3% 79.3% 6.6% 5.1% 11.9%
Note. + = positive relationship with outcome (p b 0.05); − = negative relationship with outcome (p b 0.05); 0 = no relationship with outcome; cCBT = computerized cognitive
behavior therapy; CG = control group; CT = cognitive therapy; ERP = exposure and response prevention; FLV = Fluvoxamine; IBRO = Inventory of Beliefs Related to Obsessions;
IG = intervention group; ITIQ = Intrusive Thoughts and Their Interpretations Questionnaire; OC = obsessive compulsive; OCD = Obsessive–Compulsive Disorder; OTC = Obsessive
Thoughts Checklist; OVIS = Overvalued Ideas Scale; SMT = stress management training; Y = criterion met; Na = not applicable. ?a, different predictor effects reported for measures
of Compulsive Behavior andObsessive Fear, respectively. ?b, inconsistent predictor effects reported - no relationship: Total Targets Improvement, Social Adjustment, BDI, HAM-D; negative
relationship: Total Rituals, Total Obsessions. cAs noted by a referee, hoarding is now considered a separate disorder in the DSM-5; herein it has been categorized as an OCD symptom
subtype, as it was classiﬁed as such when this review was completed.
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of depression and anxiety symptoms, a number of studies reported sig-
niﬁcant associations while others showed no relationshipwith outcome.
In relation to the broad category of OCD symptom subtypes, hoarding
symptoms were signiﬁcantly related to worse treatment outcome in
three of four relevant trials (Greist et al., 2002; Jaurietta et al., 2008;
Simpson et al., 2010). Outcomes including depressive and anxiety symp-
toms, OCD severity, and treatment continuationwere negatively affected
by hoarding symptoms, although a test of interaction showed no
association (Maher et al., 2010). One third of relevant trials supported
an association between greater OCD and anxiety severity and worse
treatment outcome, deﬁned in terms of post-treatment Y–BOCS scores
and drop-out status.
In relation to symptom subtypes other than hoarding, there was
some evidence to suggest that the category of symptom subtype may
play a role in response to treatment; although ﬁndings of speciﬁc symp-
tom subtypes were commonly based on single studies and their reliabil-
ity therefore difﬁcult to judge. Non-clinical variables, employment status
and marital/relationship status, showed an association with outcome inapproximately one third of included studies, with unemployed and sin-
gle individuals experiencing a worse prognosis. For the predictors med-
ication use, age of OCD onset, OCD related beliefs, and educational level,
no signiﬁcant associations were found in the overwhelming majority of
relevant trials. Importantly, these ﬁndings need to be considered in
light of the quality of predictor/moderator analyses as well as overall
risk of bias of included studies.
3.4.2. Quality of predictor/moderator analyses
The quality of predictor analyses varied widely (Table 4). While
most studies assessed predictors through validated measurement
tools prior to randomization, themajority of trials reported N5 outcome
predictors (mean = 8.2; SD = 8.27), few stated a priori hypotheses,
specifying the anticipated direction of the predictor effect, or used a
test of interaction to evaluate the predictor–outcome relationship. The
one exception to this overall trend was treatment expectancy which
was not assessed via a validated tool in any of the included trials
and only in 29% of assessments was this variable measured pre-
randomization.
Table 5
Risk of bias of included studies.
Author/year Sequence
generation
Allocation
concealment
Blinding-outcome
assessors
Attrition
b20%
Intention-to-treat
analysis
Tx ﬁdelity
assessed
Manualized
tx
High/uncertain/low
risk of bias
Althaus et al. (2000) ? ? ? + ? − − Uncertain
Belotto-Silva et al. (2012) − + + − + − − Low
Valpato Cordioli et al. (2003) + + + + + − + Low
Cottraux et al. (1990) ? ? + − − − − Uncertain
Cottraux et al. (2001) ? ? + + + − + Uncertain
De Araujo et al. (1995) ? ? + + − − − Uncertain
Dreessen et al. (1997) ? ? ? + + − − Uncertain
Emmelkamp et al. (1990) ? ? ? + − − − Uncertain
Fineberg et al. (2005) − − + − − − + High
Foa et al. (1984) ? ? + + − − − Uncertain
Foa et al. (2005) ? ? + − ? − + Uncertain
Freeston et al. (1997) ? − − − − + + High
Greist et al. (2002) ? ? − + + + − Uncertain
Jaurietta et al. (2008) + + − + + − + Low
Jónsson et al. (2011) ? + − − ? − − Low
Keijsers et al. (1995) ? ? ? ? − − − Uncertain
Kenwright et al. (2005) + + ? − + − − Low
Lakatos (1997) ? ? ? − − + + Uncertain
Marks et al. (1988) ? ? + − − − − Uncertain
Marks et al. (2000) + + ? + − − − Low
McLean et al. (2001) ? + + − + + + Low
Meyer et al. (2010) + + + + + − + Low
Nakao et al. (2005) ? ? + + − − ? Uncertain
Nakatani et al. (2005) ? + + + − − + Uncertain
Rector et al. (2009) ? ? + − + + + Uncertain
Rowa et al. (2007) ? ? + − − − + Uncertain
Simpson et al. (2008) + + + + − + + Low
Simpson et al. (2010) ? ? + + + + + Uncertain
Sousa et al. (2006) ? ? ? + − − + Uncertain
Tenneij et al. (2005) ? ? + + + + + Uncertain
Tolin et al. (2007) + + + + + − + Low
Tolin et al. (2011) ? ? + ? + + − Uncertain
Van Balkom et al. (1998) ? ? ? − + − + Uncertain
Van Oppen et al. (1995) ? ? ? + − + + Uncertain
Van Oppen et al. (2010) ? ? + + + + + Uncertain
Vogel et al. (2004) + − − − + + + High
Whittal et al. (2005) + ? + − + + + Uncertain
Whittal et al. (2010) ? ? + + + + + Uncertain
Note. Tx = treatment; + = criterion met; ? = unclear whether criterion met;− = criterion not met.
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A meta-analysis indicated no association between risk of bias
(dichotomized score of allocation concealment) and study effect size
(SMD = −0.93; 95% CI = −1.08 to −0.77 versus SMD = −1.12;
95% CI = −1.46 to−0.77 in trials with uncertain/high and low risk of
bias respectively). The assessment of risk of bias of included studies is
presented in Table 5. While over one half (61%) of included studies re-
ported the manualization of treatment, a formal assessment of interven-
tion ﬁdelity through the review and rating of recorded sessions was
conducted in only 37% of trials. Twenty four percent of included studies
reported an adequate method of sequence generation as outlined in
Cochrane criteria (Higgins & Altman, 2008), while 68% of studies lacked
the necessary information to judge the adequacy of the method of ran-
domization. Similarly, an appropriate method of allocation concealment
was reported in 29% of trials and 63% of studies failed to specify whether
an appropriate method was employed to conceal group allocation. Out-
come assessors were blinded in 61% of trials and around one half of in-
cluded studies (51%) reported conducting intention-to-treat analyses.
Rates of attrition below 20% at post-treatment were reported in 55% of
trials.
4. Discussion
4.1. Main ﬁndings
This systematic review synthesized the existing evidence concerning
baseline predictors/moderators of response to psychological therapies in
OCD. There was considerable overlap in the most common predictorsacross trials; trial authors regularly reported on the relationship between
OCD symptom-speciﬁc, clinical, and demographic variables and treat-
ment outcome. Interestingly, psychological variables received relatively
little attention as potential moderators of outcome (although many
may have been assessed as mediators of treatment effect and would
have been excluded from the present review). While the relevant litera-
ture generated relatively varied and ambiguous ﬁndings, a number of
variables were relatively consistently related to outcome. The box-
score analysis provided some support that hoarding pathology, increased
anxiety andOCD symptom severity, certain OCD symptom subtypes, un-
employment, and being single/not married are associated with worse
treatment outcome. Variables which failed to show an association with
outcome in the great majority of relevant trials include medication use,
age of OCD onset, OCD related beliefs, and educational level.
Reporting of predictors was not associated with age of the study,
country of publication, or treatment effect. The lack of association
with treatment effect is important; it suggests that authors are not
only conducting subgroup analyses when the primary analyses fail to
show signiﬁcant effects. The associations found between reporting
and study size and risk of bias would suggest that the existing ﬁndings
are based on the stronger studies in the literature, whichwould support
the reliability of the analyses. However, the overwhelming majority of
trials were judged as at signiﬁcant risk of bias calling for caution in
the interpretation of these ﬁndings generally. Moreover, sample sizes
were generally far from satisfactory to ensure statistical power in the
context of predictor/moderator analyses (Brookes et al., 2004).
Considering the lack of adequate statistical power and the suboptimal
quality of predictor analyses in much of the included literature, we
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evidence. Given the need for rigorous ﬁndings in applying predictor
evidence in clinical practice, we consider a test of interaction to be the
gold standard; this approach is more sensitive to the comparative beneﬁt
of treatment in different groups in a trial and is thus vital for informing
evidence based decisions about tailoring treatment. However, we ac-
knowledge that interaction analyses require larger sample sizes than
overall regression/correlation models, which are more likely to show
signiﬁcant effects, in particular in the context of relatively small studies
(e.g. Brookes et al., 2004). In light of the small sample sizes in the current
literature, viewsmay differ as to the utility of interaction tests in this con-
text. Hence, while wewould call for caution in the interpretation of asso-
ciations derived from analyses of overall and subgroup-speciﬁc effects,
the evidence on some factors (for example on hoarding pathology) may
be interpreted as consistent when adopting a less conservative stance.
4.2. Comparison with the wider literature
The box-score approach, adopted in the current study, was used to
overcome caveats in the reporting of relevant statistical data. It differs
from the narrative review of Keeley et al. (2008), although both
methods have advantages and disadvantages. The box-score provides
basic quantiﬁcation of patterns in the literature, and facilitates consider-
ation of study quality andother factors as confounders of those patterns.
The narrative reviewmay in some ways be less reliable, as the methods
of analysis and synthesis are less transparent and standardized and po-
tentially more open to subjective judgment. However, the box-score
model takes a necessarily coarse approach to the literature. This form
of analysis may therefore be less able to take account of more sophisti-
cated aspects of the studies, such as the context in which they were
conducted and subtle clinical and therapeutic issues which are better
captured in a narrative synthesis. Given those differences, there is a nat-
ural interest in the comparability of the results.
There was overlap between those variables identiﬁed as potential
predictors in the current review and that conducted by Keeley et al.
(2008). Common variables included symptom subtype and OCD symp-
tom severity. Keeley et al. (2008) found the nature of the familial envi-
ronment to be predictive of treatment response; however, most
relevant studies were excluded from the current review as they did
not meet our inclusion criteria in terms of study design or sample
characteristics. Studies included in both reviews showed inconsistent
ﬁndings regarding the role of family factors in treatment outcome for
OCD (Emmelkamp et al., 1990; Keijsers, Hoogduin, & Schaap, 1994;
Mehta, 1990). However, in the current review marital/relationship
status predicted outcome in 29% of trials where it was assessed, further
suggesting that interpersonal and familial factors may be important.
Also in line with Keeley et al. (2008) the present review shows that a
number of commonly assessed outcome predictors, including OCD
illness duration and comorbid depression, are inconsistent in terms of
their relationship with outcome. Similarly, the reviews agree that ﬁnd-
ings relating to gender, education level, and treatment expectations are
largely non-signiﬁcant.
However, there are a number of discrepancies between Keeley
et al.'s ﬁndings (2008) and those of the present review. The previous
review reported relative consistency in the relationship between cer-
tain symptom subtypes and major depressive disorder (MDD) and
worse treatment outcome. Although, the same predictors emerged in
the present review, we arrive at more tentative conclusions. Few studies
assessed the predictive role of speciﬁc symptom subtypes. While sexual/
religious, ordering/symmetry, cleaning/contamination symptom content,
and obsessive–compulsive slowness were found to be signiﬁcantly as-
sociated withworse outcome, based on single study reports, these ﬁnd-
ings cannot be considered reliable. Further research in the context of
adequately powered randomized trials, using gold standard methods
in the assessment of predictors is needed to give further support to
existing ﬁndings.The evidence for hoarding symptoms is stronger. However, acknowl-
edging the phenomenological differences between OCD and hoarding, in
the classiﬁcation of disorders in theDSM-5, hoarding is no longer consid-
ered an OCD symptom dimension (Steketee, 2010). Its relevance as a
predictor of outcome in the context of psychological treatment for OCD
is nonetheless interesting. Differences between the two disorders have
resulted in the development of treatments speciﬁcally adapted for
hoarding pathology (Muroff, Bariotis, & Steketee, 2010; Tolin et al.,
2007). Even so, the implementation of adequate interventions appears
to lag behind and hoarding disorder continues to be commonly treated
through standard ERP interventions, which fail to meet the needs of
individuals with this condition. Furthermore, hoarding may occur
comorbidlywithOCD and its effect on treatment response in this context
may be worth investigating. Lastly, the two reviews disagreed with re-
gard to the role of MDD. Citing Abramowitz(2004), Keeley et al. (2008)
state that patients with comorbidMDDmay beneﬁt from additional cog-
nitive therapy components aimed at ameliorating related thinking-
patterns. Differences in inclusion criteria (study randomization) of the
respective reviews meant that we failed to ﬁnd empirical evidence in
support of such recommendations. Those trials reporting on the relation-
ship between MDD and outcome in the present review (Belotto-Silva
et al., 2012; Valpato Cordioli et al., 2003) reported no signiﬁcant
associations.
Theﬁnding that those trialswhich assessed predictors of outcome re-
ported greater sample sizes than trialswhich failed to conduct such anal-
yses is in line with evidence reported by Sun et al. (2011). Discrepancies
between the ﬁndings of the current review and that by Sun et al. (2011)
may represent signiﬁcant differences related to the clinical areas.
4.3. Implications for research and practice
While outcome predictors are commonly reported in the ﬁeld of
mental health research, the quality of analyses is less than optimal (e.g.
Assmann, Pocock, Enos, &Kasten, 2000; Sun et al., 2012). The exploratory
analysis of predictor effects can open early avenues for future research
investigation (e.g. Pincus et al., 2011); however, the misrepresentation
of exploratory ﬁndings as conﬁrmatory may be highly problematic (e.g.
Kraemer et al., 2002). The quality of analyses reviewed here was not op-
timal. The integration of existing quality criteria into routine research
practice could assist in the rapid development of an evidence base to in-
form the personalization of interventions for OCD. Improvements in
methodology may prove particularly useful in the assessment of those
factors for which existing ﬁndings already show promising results.
In concordancewith Keeley et al. (2008), we found signiﬁcant differ-
ences in the assessment of predictors, outcome, and the deﬁnition of
treatment outcome, as well as variation in intervention types, which
make the interpretation of study ﬁndings very difﬁcult. Nonetheless,
Keeley et al. (2008) report some implications of their ﬁndings for the
psychological care of OCD patients. The authors suggest that efforts
ought to be devoted to developing targeted treatments for respective
OCD symptom dimensions. While our ﬁndings point to the signiﬁcance
of symptom subtype in treatment outcome, inconsistencies in the cate-
gorization of OCD symptom dimensions and the fact that the current
ﬁndings are commonly based on single studies call their reliability
into question. Using the opportunity of well-conducted psychotherapy
trials in OCD to assess the predictive role of speciﬁc symptom dimen-
sions and the nature and quality of the familial environment may
prove fruitful in optimizing the provision of mental health services by
allowing for treatment to be tailored on the basis of empirical evidence.
However, this said, clinical experience in support of such ﬁndings may
also be used to justify appropriate personalization of treatment based
on patient characteristics. In light of the distinction between hoarding
pathology and OCD (Steketee, 2010), recent research efforts have
been well placed to develop and assess suitable treatment techniques
for hoarding symptoms (e.g. Muroff et al., 2010; Tolin et al., 2007);
this reviewhighlights the need to routinely implement these approaches.
4 References of studies, not referred to in the text, but included in the review andmeta-
analysis are available in Appendix C.
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the predictive role of hoarding disorderwhen comorbidwith OCD versus
in isolation. Moreover, the ﬁnding that marital/relationship status and
employment status showed a likely association with outcome may indi-
cate the signiﬁcance of addressing circumstantial factors in therapy,
whichmay otherwise detract from treatment and lessen its effectiveness.
However, the successful implementation of such changes requires the
careful consideration and planning of the analyses of third variables at
all stages of the research process—including early planning of predictor
analyses in the initial research stages, reporting of a priori hypotheses
of anticipated effects, the adoption of adequate statistical analyses, and
full reporting of analytic methods and resultant ﬁndings.
4.4. Strengths and limitations of the ﬁndings
This reviewused a rigorous approach to the identiﬁcation of relevant
trials.Moreover, all datawas extracted independently by two reviewers,
and reliability checks were conducted. By including foreign language
studies and dissertations, the authors aimed to reduce the effect of pub-
lication bias, although unpublished research is likely underrepresented
in the review. Assessing the impact of predictors on outcome through a
meta-analytic approach was not possible for reasons outlined. The box-
score approach, adopted in the current review, has known limitations,
as the classiﬁcation of effects in terms of statistical signiﬁcance and di-
rection fails to consider the magnitude of reported effects (Green &
Hall, 1984) and may therefore result in taking an overly conservative
stance to interpreting the evidence and wrongly accepting the null hy-
pothesis. An additional issue is the lack of consensus on the interpreta-
tion of ﬁndings, in terms of the number and consistency of ﬁndings
required to make clinical or policy recommendations. Green and Hall
(1984) highlighted that box-score analyses can be misinterpreted if an-
alysts fail to take into account how many signiﬁcant results might be
expected under the null hypothesis. They suggested that signiﬁcant
support could be assumed for predictors where around 30% of studies
reported signiﬁcant ﬁndings in the hypothesized direction (Green &
Hall, 1984, p. 41). To reduce the risk of underestimating potential pre-
dictor effects, we assessed ﬁndings in line with the suggestions made
by the authors (Green & Hall, 1984) and performed a balanced discus-
sion of the presented evidence. Counting the proportion of studies
reporting signiﬁcant effects ignores the quality of the methodology un-
derlying those analyses. A key strength of the current review was the
comprehensive assessment of overall risk of bias and the quality of pre-
dictor analyses, thus allowing the reader to evaluate the credibility and
reliability of reported predictor effects. There was signiﬁcant variation
in reporting of multiple and varying measurement time-points, forms
of analyses, and measurement tools within and across trials, but we
sought to achieve the greatest possible consistency in our extraction
analyses.
5. Conclusion
While there is clearly a strong interest in predictors andmoderators
of outcome, and an increasing body of literature to guide the conduct of
high quality research in this context (Brookes et al., 2001; Emsley, Dunn,
& White, 2010; Pincus et al., 2011; Rothwell, 2005; Sun et al., 2012;
Wang, Lagakos, Ware, Hunter, & Drazen, 2007), only few consistent
ﬁndings can be drawn from the existing literature, highlighting the
gap between best practice and its implementation in applied mental
health research. It is promising that authors commonly report analyses
of predictor effects; however, the potential of such analyses has not
beenmaximized, as analyses only rarely meet published quality criteria
(Pincus et al., 2011; Sun et al., 2012). Considering the signiﬁcant applied
role of these analyses in personalized patient care and the optimal use of
limited healthcare resources, it appears surprising that this domain has
not received more mention in research guidelines. In line with Emsley
et al. (2010) we conclude that the theoretical and methodologicalfoundation has been laid for conducting empirically sound research
into prediction effects, and the principal focus ought to be on applying
this knowledge.
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